Acutaas Chemicals Ltd has scheduled a Board Meeting on April 30, 2026, to approve audited financial results for Q4 and FY26 and consider a final dividend. The trading window for dealing in company shares remains closed until May 2, 2026.
IDBI Bank Ltd has scheduled a Board of Directors meeting on April 30, 2026, to consider and approve audited financial results for the quarter and year ended March 31, 2026. The trading window for dealing in securities remains closed until May 02, 2026.
Supreme Infrastructure India Ltd reported progress in recovering ₹45.47 Crore in receivables from MMRDA. The authority has constituted a Dispute Resolution Committee, which held its preliminary meeting on April 10, 2026. This marks a significant step toward adjudicating legacy claims related to flyover projects at Rajnoli and Mankoli Junctions.
Rossell Techsys Ltd shared a press release regarding a Deccan Herald article outlining its strategic growth plans. Management reiterated its targets to achieve growth in two years matching its previous 14-year expansion. No new financial data or material non-public information was disclosed beyond previously discussed earnings calls and presentations.
Bharat Heavy Electricals Limited (BHEL) has appointed Ms. Aruna Gulati as General Manager & Head of its Solar Business Division in Bengaluru. The appointment, effective April 25, 2026, strengthens the company's leadership in the solar energy segment. Ms. Gulati is designated as Senior Management Personnel and will report to the Director (IS & P).
Bharat Heavy Electricals Limited (BHEL) has appointed Ms. Aruna Gulati as General Manager & Head of the Solar Business Division (SBD), Bengaluru. Categorized as Senior Management Personnel, she assumed the role effective April 25, 2026, reporting to the Director (IS & P).
Kings Infra Ventures hosted senior representatives from South Korea-based LX International Corp. to explore a strategic partnership in the global seafood sector. The collaboration focuses on expanding trade volumes and deepening cooperation in seafood supply chains. This visit underscores mutual intent to scale business engagement across global markets.
Craftsman Automation Limited has scheduled a board meeting for May 7, 2026. The board will consider audited standalone and consolidated financial results for the year ended March 31, 2026, and recommend a final dividend. The trading window remains closed until May 9, 2026.
Craftsman Automation Limited has scheduled a board meeting for May 7, 2026, to approve audited annual financial results and recommend a final dividend. The trading window for designated persons is closed from April 1 to May 9, 2026.
Craftsman Automation Ltd has scheduled a Board Meeting on May 7, 2026, to approve audited financial results for the year ended March 31, 2026. The board will also consider recommending a final dividend. The company's trading window remains closed until 48 hours after the results are declared.
Elecon Engineering Company Price Movement Clarification
Elecon Engineering clarified to the NSE that there is no pending price-sensitive information or announcements causing recent stock price movements. The company confirmed compliance with SEBI Listing Regulations and stated it is not connected with any price/volume fluctuations.
Larsen & Toubro's subsidiary, L&T Realty Properties, acquired a 100% stake in International Green Scapes Ltd. This acquisition secures 20 acres in Gurugram with 3.6 million square feet of development potential, marking L&T's entry into the NCR real estate micro-market.
Elecon Engineering Company Price Movement Clarification
Elecon Engineering Company Ltd clarified to BSE that there is no pending price-sensitive information or announcements. The company stated it is in compliance with SEBI Listing Regulations and is not connected with recent stock price or volume movements.
Anlon Healthcare Limited has allotted 26,57,57,500 bonus equity shares of Rs. 2/- each in a 1:1 ratio to eligible shareholders. This allotment increases the company's paid-up equity share capital to Rs. 106.30 Crore, divided into 53,15,15,000 equity shares.
Garment Mantra Lifestyle Limited's subsidiary secured an export order worth ₹8.28 Crore from UAE-based AL Rahmat Textiles LL.C. The contract for dyed and printed fabrics is scheduled for execution by October 2026, marking a strong start to the financial year in the Middle East market.
Bharat Forge, in partnership with VRDE (DRDO) and TASL, successfully co-created and flagged off the Vikram VT 21 advanced armoured platforms. Developed in under three years, the platforms have cleared technical evaluations for the Ministry of Defence, readying them for the Indian Armed Forces and global export markets.
TARIL achieved record FY26 consolidated revenue of ₹2,509cr and PAT of ₹272cr. Management is focused on backward integration and HVDC entry to drive margin expansion and reach a $1 billion revenue target within few years.
Cohance Lifesciences appointed Umang Vohra as Executive Chairman (effective May 1, 2026) and Group CEO (effective May 20, 2026). He succeeds Vivek Sharma, who is stepping down for personal reasons but will remain as an advisor for nine months to ensure a smooth transition. Mr. Vohra previously served as MD and CEO of Cipla.
Cohance Lifesciences approved the appointment of Mr. Umang Vohra as Chairman and Group CEO, succeeding Mr. Vivek Sharma who resigned effective April 30, 2026. The Board also approved the 'Cohance Lifesciences Limited – Employee Stock Option Plan, 2026' covering 2.59 crore options. These leadership transitions and incentive plans are subject to shareholder approval via postal ballot.
Tata Elxsi Limited has announced a leadership transition. Mr. Gaurav Bajaj has resigned as Chief Financial Officer, effective May 29, 2026. He will be succeeded by Mr. Nalin Rana, effective May 30, 2026. Mr. Rana joins from Tata Sons and brings 17 years of experience in strategic finance and investment banking.
Veranda Learning Solutions' shareholders approved the demerger of its commerce vertical into J.K. Shah Commerce Education Limited. The restructuring aims to simplify group structure and unlock shareholder value through a focused entity. The scheme now proceeds for final NCLT and regulatory approvals.
Tata Elxsi Limited announced that Mr. Nalin Rana will succeed Mr. Gaurav Bajaj as Chief Financial Officer, effective May 30, 2026. Mr. Bajaj resigned to pursue external opportunities, effective May 29, 2026. Mr. Rana, currently a senior leader at Tata Sons, brings 17 years of experience in strategic finance and investment banking.
Transformers & Rectifiers (India) Bags ₹152.8 Cr Order
Transformers and Rectifiers (India) Limited secured an export order worth approximately ₹152.83 Crore (USD 16.26 million) from PDC AK LPIV, LLC. The contract involves manufacturing five transformers for international delivery by mid-2027, highlighting the company's growing global presence in the transformer manufacturing sector.
Sigma Advanced Systems secured a seven-year agreement with Rolls-Royce valued at approximately ₹3,800 Crore (£300 million). The company will manufacture and supply high-precision aerospace components from its India and UK facilities. This strategic partnership provides long-term revenue visibility and strengthens its position in the global aerospace supply chain.
Jagsonpal Pharmaceuticals Ltd secured shareholder approval for a buyback of up to 16 lakh equity shares at ₹250 each. The transaction, totaling ₹40 Crore, aims to optimize capital allocation and improve earnings per share.
Premier Energies Ltd launched India's first All-Black G12R DCR Solar Module series, NeoBlack, at RenewX Chennai. The 600-630 Wp modules utilize next-generation TOPCon technology for residential and premium commercial rooftops. This design-led innovation aims to accelerate urban solar adoption by addressing visual integration needs with modern architecture.
Sun Pharmaceutical Industries Acquisition Worth ₹110,450 Cr
Sun Pharma has agreed to acquire 100% of Organon & Co. for US$ 14.00 per share in an all-cash deal valued at ₹110,450 Crore (EV). The acquisition marks Sun Pharma's entry into biosimilars and significantly expands its global Women's Health portfolio. The transaction is expected to close in early 2027.
Jagsonpal Pharmaceuticals Limited announced the successful passage of a postal ballot resolution for an equity share buy-back worth ₹40 Crore. Shareholders approved the buy-back of up to 16,00,000 shares at ₹250 per share with a 99.99% majority. The resolution was deemed passed on April 24, 2026.
Reliance reported strong FY26 performance with 10% revenue growth and 13.5% EBITDA growth. Strategy focuses on 5G monetization, retail hyperlocal expansion, and commissioning New Energy Giga-factories.